Samaritan Pharmaceuticals, Inc. Signs Exclusive License to Commercialize Two of EUSA Pharma's Marketed Oncology Drugs in Greece and Cyprus

LAS VEGAS, March 11, 2008 (PRIME NEWSWIRE) - Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC.OB),a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has signed an exclusive distribution agreement for the territory of Greece and Cyprus with EUSA PHARMA Ltd., for two drugs: ERWINASE (Erwinase chrysanthemi L-asparaginase, crisantaspase) and KIDROLASE (Escherichia coli L-asparaginase).